You are here




Investor Relations

Analyst Coverage

Vertex Pharmaceuticals is covered by the following analysts.

Analyst Coverage
Firm Analyst
Brian Skorney
Bank of America Merrill Lynch
Ying Huang, Ph.D.
Geoffrey Meacham, Ph.D.
BMO Capital Markets
Do Kim
Dane Leone
Citi Research
Robyn Karnauskas, Ph.D.
Cowen & Co.
Phil Nadeau, Ph.D.
Credit Suisse
Alethia Young
Deutsche Bank Securities
Navin Jacob
Goldman Sachs
Terence Flynn, Ph.D.
Guggenheim Securities
Tony Butler, Ph.D.
HC Wainwright
Andrew Fein
J.P. Morgan
Cory W. Kasimov
Michael Yee
JMP Securities
Liisa Bayko
Geoff Porges, Ph.D.
Maxim Group
Jason McCarthy
Morgan Stanley
Matthew Harrison
Needham & Company
Alan Carr, Ph.D.
Hartaj Singh
Piper Jaffray
Edward Tenthoff
Raymond James
Laura Chico
Brian Abrahams, M.D.
Adam Walsh, M.D.
UBS Equities
Carter Gould
William Blair
Katherine Xu

Please note that any opinions, estimates or forecasts regarding Vertex Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vertex Pharmaceuticals or its management. Vertex Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.